BMS recently added a multiple myeloma drug to its 340B contract pharmacy restrictions and exempted New Mexico health centers from its policy.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.